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Key points
●● A common feature of muscular dystrophy is respiratory failure, i.e. the inability of the respiratory 
system to provide proper oxygenation and carbon dioxide elimination.
●● In the lung, respiratory failure is caused by recurrent aspiration, and leads to hypoxaemia and 
hypercarbia.
●● Ventilatory failure in muscular dystrophy is caused by increased respiratory load and respiratory 
muscles weakness.
●● Respiratory load increases in muscular dystrophy because scoliosis makes chest wall compliance 
decrease, atelectasis and fibrosis make lung compliance decrease, and airway obstruction makes 
airway resistance increase.
●● The consequences of respiratory pump failure are restrictive pulmonary function, hypoventilation, 
altered thoracoabdominal pattern, hypercapnia, dyspnoea, impaired regulation of breathing, 
inefficient cough and sleep disordered breathing.
Educational aims
●● To understand the mechanisms leading to respiratory disturbances in patients with muscular dystrophy.
●● To understand the impact of respiratory disturbances in patients with muscular dystrophy.
●● To provide a brief description of the main forms of muscular dystrophy with their respiratory 
implications.
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Muscular dystrophy is a group of inherited myopathies characterised by progressive skeletal muscle 
wasting, including of the respiratory muscles. Respiratory failure, i.e. when the respiratory system fails 
in its gas exchange functions, is a common feature in muscular dystrophy, being the main cause of 
death, and it is a consequence of lung failure, pump failure or a combination of the two. The former is 
due to recurrent aspiration, the latter to progressive weakness of respiratory muscles and an increase 
in the load against which they must contract. In fact, both the resistive and elastic components of the 
work of breathing increase due to airway obstruction and chest wall and lung stiffening, respectively.
The respiratory disturbances in muscular dystrophy are restrictive pulmonary function, 
hypoventilation, altered thoracoabdominal pattern, hypercapnia, dyspnoea, impaired regulation 
of breathing, inefficient cough and sleep disordered breathing. They can be present at different 
rates according to the type of muscular dystrophy and its progression, leading to different onset 
of each symptom, prognosis and degree of respiratory involvement.
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According to their aetiology, chronic neurological 
diseases can be categorised into neuropathic and 
myopathic disorders. The latter can be acquired 
or congenital. Muscular dystrophy is a group 
of congenital myopathies characterised by a 
variable combination, distribution and severity 
of 1) progressive skeletal muscle wasting and 
weakness, 2) defects in muscle proteins, and 
3) death of muscle cells and tissue [1–3].
Respiratory failure is a common feature in almost 
all forms of muscular dystrophy, being the main 
cause of death in these patients, together with 
heart dysfunction. It is defined as the inability to 
perform adequately the fundamental functions 
of respiration: to deliver oxygen (referred to as 
oxygenation failure) to the blood and to eliminate 
carbon dioxide from it (referred to as ventilatory 
failure). The causes of ventilatory failure can involve 
the respiratory centre, the respiratory muscles or 
their nerve supply, and abnormalities of the chest 
wall and pulmonary (lung and airway) systems.
In muscular dystrophy, when the lung is 
involved, the main cause is recurrent aspiration, 
as a consequence of either impaired swallowing 
or episodes of gastro-oesophageal reflux. With 
the former, aspiration occurs from above when 
food, saliva, or liquids are breathed into the 
lungs, whereas with the latter aspiration occurs 
from below by re-appearance of a bolus of food 
and/or stomach content into the pharynx. 
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The primary manifestation of respiratory failure 
with lung involvement is hypoxaemia secondary 
to intrapulmonary shunt resulting from excessive 
dead ventilation. Hypercarbia may also occur [3].
Muscular dystrophy affects all skeletal muscles. 
These also include the respiratory muscles, which 
constitute the respiratory pump, the role of which is 
to move air into the lung, therefore overcoming the 
elastic and resistive forces exerted by the chest wall 
and lungs. The impairment of respiratory muscles 
(that in muscular dystrophy become progressively 
weak and/or fatigued), combined with the high load 
against which the pump has developed its pressure, 
determine ventilatory failure.
Causes of respiratory load 
increase
As shown in figure 1, the elastic properties of the 
lung are altered in muscular dystrophy patients, 
with the lung becoming less distensible. The cause 
of the reduced distensibility of the lung in muscular 
dystrophy is still not known. Different hypothesis 
have been proposed: incomplete maturation of 
lung tissue in case of congenital disease, micro- 
or macroatelectasis induced by hypoventilation, 
increase in alveolar surface tension, fibrosis induced 
by recurrent aspiration and parenchymal disease. The 
reasons for the reduction in lung compliance (CL), 
therefore, still need to be demonstrated with further 
dedicated studies. An important factor that, in theory, 
is capable of reducing lung distensibility is breathing 
at low lung volume, which is typical in muscular 
dystrophy. An additional mechanism is the chronic 
and progressive impairment of respiratory muscles 
that limits the range of activity of the lung. The elastic 
properties of a system, in fact, are partly determined by 
the stress to which the system is subjected. Inspiratory 
muscle weakness truncates the upper part of the static 
pressure–volume curve in these patients (figure 1). 
The position of total lung capacity (TLC), in fact, is the 
result of the balance between the static elastic recoil 
pressure of the lung and the pressure generated by 
inspiratory muscle contraction. The latter is reduced 
and, therefore, the former is reduced at TLC and this 
alters the position of the expiratory curve with static 
expiratory compliance to reduce.
The elastic properties of the chest wall are also 
altered in muscular dystrophy patients, with the 
chest wall being stiffer and its compliance (CCW) 
decreased of about two-thirds of healthy subjects 
(figure 1). A combination of factors contributes 
to this: muscle atrophy and osteoporosis, both 
due to inactivity; extra-articular contractures; 
progressive degeneration of articular cartilage; and 
ultimately, kyphoscoliosis often accompanied by 
chest wall deformity, which is a further mechanical 
disadvantage for the respiratory muscles. Moreover, 
since ribcage compliance decreases and abdominal 
compliance increases in tetraplegic patients, it 
seems reason to speculate that also in muscular 
dystrophy patients, the ribcage compartment is 
the main contributor to the reduction of CCW. The 
reduced ribcage movements, a consequence of 
impaired respiratory muscles and decreased physical 
activity, lead to ankylosis in the costovertebral and 
costosternal joints, and to stiffening of ribcage 
tissue, such as tendons and ligaments [2–7].
Upper airway (bulbar) musculature can also 
be involved in muscular dystrophy patients. The 
direct consequences are impairment of swallowing, 
speech impediments and ensuing significant airway 
obstruction during inspiration [8].
The combination of weakened respiratory muscles 
with the less compliant chest wall and lungs make 
pressure swings needed to change lung volume 
increase and the elastic component of the work 
of breathing (WOB) increase. Inspiratory airway 
obstruction makes the resistive component of 
WOB increase. As a result, both the loads against 
which the respiratory muscles must act and their 
WOB increase. With the evolution of the disease, 
therefore, muscular dystrophy patients have to deal 
with a progressive imbalance between the load to be 
overcome and the capacity to overcome it. This is a 
vicious cycle that predisposes respiratory muscles to 
fatigue and, ultimately, patients to respiratory failure.
Respiratory muscles
The diaphragm is the most important 
inspiratory muscle. External intercostal muscles, 










Figure 1 Representative, schematic diagram showing the pressure–volume curves of the respi-
ratory system (RS, blue curves) and its two components, i.e. the chest wall (CW, green curves) 
and lung (L, red curves), for healthy subjects (thin curves on the left panel) and patients with 
muscular dystrophy (thick curves on the right panel). The maximal inspiratory pressure (PImax) is 
also reported (dashed curves). Muscular dystrophy patients are characterised by 1) reduced total 
lung capacity (TLC); 2) reduced compliance of chest wall (CCW), lungs (CL) and respiratory system 
(slope of the corresponding pressure–volume curves); 3) reduced PImax; 4) reduced inspiratory 
capacity (IC=TLC−FRC); and 5) reduced expiratory reserve volume (ERV=FRC−RV). Functional 
residual capacity (FRC) may be lower or even normal. Residual volume (RV) is not significantly 
different than in healthy subjects. PImax represents the force of respiratory muscles, while the 
volume variations are the resulting action of their contraction. The fact that PImax and lung 
volumes are both reduced indicates that the respiratory muscles, and therefore the respiratory 
pump, are affected by muscular dystrophy. The compliance of the respiratory system reduces 
because it decreases in both its components: 1) CL, due to lung atelectasis and fibrosis, the former 
being a consequence of hypoventilation, induced by respiratory muscles involvement, the latter 
of recurrent aspiration, induced by the involvement of bulbar muscles; and 2) CCW, due to of the 
onset of scoliosis, induced by the involvement of trunk muscles.
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accessory to inspiration, becoming more active 
in the seated position and during maximal 
manoeuvres and efforts. The contraction of the 
inspiratory muscles decreases pleural pressure in 
order to create a pressure gradient that makes air 
flow into the lung to ventilate it. As a result, the lung 
and the ribcage expand. The downward, piston-like 
movement of the diaphragm increases also intra-
abdominal pressure, causing an outward movement 
of the abdominal wall [9–12].
The contraction of the abdominal muscles 
(transversus, rectus, and internal and external 
oblique muscles) increases intra-abdominal 
pressure, making air flow out of the lung and the 
abdominal wall move inward. When the internal 
intercostal muscles contract, they exert a large 
torque that lowers the ribs and increases pleural 
pressure to drive air outside the lung. Abdominal 
and internal intercostal muscles are therefore 
expiratory muscles [13, 14]. At rest, during quiet 
breathing, expiration is normally passive and driven 
by the elastic recoil of the lung, whereas during 
exercise there is an immediate recruitment of 
abdominal muscles and, to a lesser extent, of the 
expiratory rib cage muscles [9, 11, 12].
The respiratory pump therefore consists in 
a coordinated activity of all respiratory muscles 
to develop the pressures required to drive air in 
and out of the lung, and to move the ribcage and 
the abdomen in a coordinated and synchronous 
way. It is possible to breathe with only one set of 
respiratory muscles but unwanted effects, like 
thoracoabdominal paradoxical movement (i.e. one 
compartment expands while the other deflates), 
are likely to occur.
●● The isolated contraction of the diaphragm 
inflates the lungs, and makes the abdomen 
expand and the ribcage move inwardly. This 
is due to the lack of ribcage muscle tone to 
counteract the effect of negative pleural pressure 
swings on the thoracic compartment [9–11].
●● The isolated contraction of the accessory 
inspiratory muscles inflates the lungs, and makes 
the ribcage expand and the abdomen move 
inwardly. This is due to the lack of abdominal 
muscle tone to counteract the effect of negative 
pleural pressure swings, transmitted through 
the passive diaphragm, on the abdominal 
compartment [9, 11, 12].
●● The isolated contraction of abdominal muscles 
deflates the lungs, and makes the abdomen move 
inwardly and the ribcage expand. This is due to 
the lack of ribcage muscle tone to counteract 
the effect of positive abdominal pressure swings, 
transmitted through the passive diaphragm, on 
the thoracic compartment [9–11].
Thoracoabdominal asynchrony is an inefficient 
and costly way to breathe, as part of the respiratory 
muscle contraction is wasted to distort the chest 
wall rather than to inflate the lungs [11].
Respiratory muscle weakness, 
fatigue and strength
The definition of weakness for a respiratory 
muscle is the inability to generate adequate levels 
of pressure and volume in the respiratory cycle, 
whereas fatigue for respiratory muscles is defined as 
their inability to sustain a given pressure in response 
to a constant load.
All muscular dystrophy patients experience 
respiratory muscle weakness, although to different 
extents according to the specific form of the disease 
and to its progression. Sometimes the diagnosis of 
respiratory muscle weakness is delayed because the 
daily activity of muscular dystrophy patients is often 
reduced and their ventilatory demands are therefore 
limited. For this reason, the onset of respiratory 
insufficiency can be subtle to the point that most 
muscular dystrophy patients are not aware that they 
have lost respiratory muscle strength.
The tension time index relates the force 
developed by the inspiratory muscles to the time 
that they are being used and it is proposed as an 
index of respiratory muscle fatigue. A group of 
children with neuromuscular disease, including 
muscular dystrophy, show elevated values of the 
tension time index. This indicates that the whole 
inspiratory muscles are prone to fatigue from 
childhood in some forms of muscular dystrophy [16]. 
As a consequence, respiratory muscle strength, both 
for inspiratory and expiratory muscles, is reduced in 
muscular dystrophy patients [17].
Respiratory muscle failure may occur due 
to either increased WOB beyond the muscle 
endurance capacity or weakening of the muscle 
so that they cannot even sustain the WOB of normal 
quiet breathing.
The multiple impacts of respiratory muscle pump 
failure are summarised as follows
●● Restrictive pulmonary function Respiratory 
muscle weakness has a direct (loss of expanding 
pressure and of elastic recoil) and an indirect 
(changes in CL and CCW) impact on pulmonary 
function, resulting in reduced TLC, reduced 
vital capacity (figure 2) and normal or reduced 
functional residual capacity. The Tiffenau index, 
i.e. the ratio between forced expiratory volume in 
1 s and forced vital capacity (FVC), may be either 
normal or even high [2, 15, 18]. The restriction 
of the chest wall is further worsened by scoliosis, 
which develops in almost all muscular dystrophy 
forms in which postural muscles are involved.
●● Hypoventilation and thoracoabdominal pattern 
With the progression of the disease and 
respiratory muscle involvement, muscular 
dystrophy patients are more prone to rapid, 
shallow breathing (RSB) (figure 2), and 
asynchronous movement between the 
ribcage and abdomen. RSB is the result of the 
combination of at least three factors: respiratory 
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muscle weakness, and vagal and nonvagal 
afferents. Vagal afferents come from the lung; 
the nonvagal from the stiffened chest wall and 
weak respiratory muscles. These afferents are 
responsible for shortening the inspiratory time, 
therefore truncating the tidal volume and making 
RSB increase [17]. RSB is suggested as a strategy 
these patients adopt to reduce their elastic work 
within breath and their perception of dyspnoea. 
Muscular dystrophy progressively impairs 
the respiratory muscles. Thoracoabdominal 
movements, therefore, may range from being 
almost synchronous to completely paradoxical, 
in the worse cases, according to the respiratory 
muscle group (or groups) involved. The main 
consequences of RSB and chest wall distortion 
are 1) areas of atelectasis, worsening the 
already restricted lungs; 2) increased cost of 
breathing, fatiguing the respiratory muscles; 
and 3) hypercapnia that triggers the reflex that 
makes ventilation increase in order to access to 
oxygen, a further factor for respiratory muscle 
fatigue [17].
●● Hypercapnia Chronic carbon dioxide retention 
is shown to be strongly related not only to 
respiratory muscle weakness, but in particular 
to the dynamic elastance of the lung (ElDYN). 
ElDYN reflects the elastic load of the lung per 
unit of maximal inspiratory muscle strength. 
The fact that it is increased in muscular 
dystrophy patients, especially when expressed as 
percentage of pleural pressure during maximal 
sniff, indicates an imbalance between the load of 
the inspiratory muscles and their strength [17].
●● Dyspnoea The weakness of the diaphragm causes 
orthopnoea, whereas breathlessness occurs in 
the upright position in the case of intercostal 
muscle weakness. When the bulbar muscles 
are also involved, it is difficult for the patient to 
distinguish between breathing difficulty and the 
sensation of choking [18].
●● Impaired regulation of breathing Muscular 
dystrophy is also characterised by altered 
feedback from the receptors of the respiratory 
muscles. A degenerative change in the spindle 
of the muscle, with consequent impairment of 
reflexes, is also present in muscular dystrophy 
patients. The main consequence of such 
feedback disturbance is an impaired control of 
breathing. A further factor that may alter the 
breathing pattern in these patients is a reduced 
mechanoreceptor output from tendons [19–21].
●● Cough The essential features of effective cough 
function are bulbar muscles to keep the glottis 
completely closed in the compressive phase 
and co-activation of antagonist respiratory 
muscles to generate a deep inspiratory volume 
of cough, and sufficient pressure to compress 
and expel the gas. Antagonist respiratory muscle 
co-activation is also needed to counteract the 
chest wall distortion secondary to the violent 
muscular activity during cough. The bulbar and 
respiratory muscle involvement in muscular 
dystrophy, therefore, makes cough inefficient 
in these patients. The operating volume is the 
volume inspired at the end of the inspiratory 
cough phase. It is shown to be the most 
important determinant of peak cough flow, 
as it affects the expiratory muscle length and, 
therefore, their efficiency of contraction. The 
combination of inspiratory muscle weakness, 
which prevents the patient from taking a deep 
breath, and the decreased CCW, which decreases 
the available chest wall excursion, limits the 
operating volume required for an effective 
cough. When glottis dysfunction is present, 
adequate pressures to develop the compressive 
forces for expectoration of airway secretions are 
not reached. The effectiveness of the cough is 
further diminished. The expiratory cough phase, 
when secretions have to be expelled, is limited 
by 1) expiratory muscles weakness; 2) a stiffened 
chest wall that limits expiration; 3) a mechanical 
disadvantage of the expiratory muscles, because 
of not being properly stretched to their optimal 
point of contraction by the restricted operational 
point; 4) limited passive elastic recoil of the 
lungs during expiration, because of their limited 
inflation; and 5) diminished cross-sectional 
diameter of the airways that are not fully dilated 
because the lung is not fully inflated. This 
increases airway resistance during expiration, 
further limiting cough flow rates [2, 22, 23].
●● Sleep disordered breathing (SDB) Upper airway and 
respiratory muscle weakness both contribute 
to enhancing the likelihood of SDB in muscular 
dystrophy patients. Upper airway weakness 
worsens during sleep and induces airway 
obstruction, therefore predisposing muscular 
dystrophy patients to obstructive apnoeas 
or hypopneas. High body mass index and 
craniofacial abnormalities (i.e. retrognathia or 













Figure 2 Lung volume variations during quiet breathing (grey lines) and vital capacity (blue 
lines) in an healthy subject (left) and a muscular dystrophy patient (right). Muscular dystrophy 
patients are characterised by reduced vital capacity, and rapid and shallow breathing at rest, 
i.e. reduced tidal volume and increased respiratory rate. RV: residual volume; FRC: functional 
residual capacity.
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unfavourable upper airway collapse during sleep, 
and they may both be characteristic features 
in muscular dystrophy. Respiratory muscle 
weakness leads to hypoventilation, due to 
limited tidal volume, during rapid eye movement 
(REM) and non-REM sleep. While sleeping, 
minute ventilation falls because the ventilatory 
drive decreases. This is a consequence of the 
reduced chemosensor feedback in response 
to the rise in carbon dioxide partial pressure 
and bicarbonate retention. In contrast, upper 
airway resistance increases because the tone 
of the pharyngeal dilator muscles decreases. 
These features further worsen during REM 
sleep, in which the tone of all the skeletal 
muscles abruptly falls, with the exception of 
the extraocular muscles and of the diaphragm. 
As a result, patients with severe upper airway 
and respiratory muscle weakness experience a 
significant drop in oxygen saturation and rise 
in carbon dioxide tension. Hypoventilation and 
the consequent abnormalities in gas exchange 
lead to frequent arousals. On the one hand, 
frequent arousals are a protective mechanism to 
minimise blood gas worsening, by restoring tone 
and activity of respiratory and airway muscles; 
on the other hand, they reduce sleep time and 
efficiency, resulting in daytime somnolence and 
fatigue [24, 25].
The aforementioned generalised causes of 
respiratory disturbances in muscular dystrophy 
are summarised in figure 3. They can be present 
at different rates according to the type of muscular 
dystrophy and its progression. The degenerative 
nature of the disease, in fact, may lead to different 
onset of each symptom, prognosis and degree of 
respiratory involvement. For this reason, a brief 
description of the principal muscular dystrophies, 
with particular attention to the respiratory 
implications (where available), will follow.
Becker muscular dystrophy
Becker muscular dystrophy (BMD) is a late-onset 
form of X-linked muscular dystrophy characterised 
by slow progression. Respiratory function and 
spirometry are almost within normal values. Chest 
wall volumes and thoracoabdominal volumes are 
also similar to those of healthy subjects during quiet 
breathing. In a small percentage of BMD patients, 
lung restriction occurs but not as severely as the 
problems seen in Duchenne muscular dystrophy 
[2, 26].
Congenital muscular dystrophy
Congenital muscular dystrophy is a group of rare 
muscular dystrophies, with an incidence rate of one 
in 100 000 births, with dystrophic symptoms present 
at birth or in the first months of life. Respiratory 
implications are reported in the first decade of life. 
The worsening of scoliosis in these children starts 
a vicious cycle of pulmonary restriction, ribcage 
rigidity and nocturnal hypoventilation. Bulbar 
involvement is not reported [2, 27, 28].
Distal muscular dystrophy
Distal muscular dystrophy is uncommon and can 
either be inherited or a consequence of a sporadic 
mutation. It is characterised by progressive 
























Figure 3 Schematic diagram summarising the generalised causes of respiratory disturbances in muscular dystrophies. 
Raw: airway resistance; WOBEL: elastic component of work of breathing; WOBRES: resistive component of work of breathing; 
↑: increment; ↓: decrement.
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changes, rather than dystrophic changes, are seen 
on muscle biopsy, some authors think that it might 
be more considered as a myopathy rather than a 
dystrophy. Respiratory involvement is uncommon 
but recently, a high risk of abnormal respiratory 
function is shown with progressive worsening in 
late-onset distal myopathy due to MATR3 mutation 
[1, 29, 30].
Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is the most 
common inherited progressive myopathy. Having 
an X-linked recessive inheritance pattern, it affects 
only males with an incidence of one in 3300 live 
births. It is caused by progressive lack of dystrophin, 
a cohesive protein that supports muscle fibre 
strength, increases muscle stiffness and stabilises 
the sarcolemma. Its absence is associated with loss 
of all skeletal muscle function over time. Initially, the 
proximal lower limb muscles are affected, followed 
by the shoulder muscles, the distal limb muscles 
and the respiratory muscles. The consequences are 
ambulation lost around the age of 10–11 years, 
progressively worsening scoliosis and breathing 
difficulties. Without any intervention, death occurs 
at around 19 years due to cardiac and respiratory 
failure. With the progression of the disease, 
patients tend to hypoventilate and increase their 
RSB index. The breathing rate tends to increase, 
while tidal volume progressively decreases because 
of a reduction of the abdominal contribution, 
particularly in the supine position, which is an 
index of the action of the diaphragm (figure 4). 
With the progression of DMD, the diaphragm 
is characterised by an increased fatigue index, 
reduced action, paradoxical cephalic movement 
(in the worst cases) and pseudohypertrophy due 
to infiltration of connective tissue. The diaphragm in 
DMD therefore becomes progressively weaker than 


























































Figure 4 a) Ribcage (top), abdominal (middle) and chest wall (bottom) volume variations during spontaneous breathing in 
supine position in a 17-year-old DMD patient. While tidal volume is constant, the thoracoabdominal pattern alternatively 
changes by passing from abdominal (A, blue lines) to thoracic (B, grey lines) predominance. b) “Loops” (i.e. volume changes 
of the abdomen versus the ribcage) in representative breaths when either the abdomen (A) or the ribcage (B) are prevalent. 
The breath of a healthy peer (control) is also reported. The arrows indicate the direction of the loops, i.e. the relative action 
of inspiratory ribcage muscles and the diaphragm [31]. In healthy subjects, both ribcage and abdomen expand during 
inspiration, with the latter being predominant. This indicates that in the supine position, the diaphragm is the leading 
muscle of inspiration, with a reduced contribution of ribcage muscles that mainly act to avoid chest wall distortion. The 
DMD patient therefore alternates periods of breathing in which inspiration is led by the diaphragm (A) and periods in which 
ribcage muscles are the leading inspiratory muscles (B). These thoracoabdominal “alternans” are thought to be a strategy 
adopted to cope with diaphragmatic weakness and fatigue. Note that, however, when the diaphragm leads inspiration (A), 
its action is reduced compared to the healthy subject (i.e. reduced abdominal expansion) and this is an index of diaphrag-
matic weakness.
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without any intervention, older patients are likely 
to approach diaphragmatic fatigue.
FVC expressed as percentage of the predicted 
values linearly declines with age in DMD. Absolute 
values of all spirometric and plethysmographic 
parameters follow a pathognomic pattern 
characterised by ascending, plateau and descending 
phases. Maximal inspiratory and expiratory 
pressures are lower in DMD compared to normal 
values, and decrease with age, with the latter being 
globally lower than the former. These patients are 
also characterised by an altered tissue composition 
of sternocleidomastoid muscle. Taken together, 
these results indicate that the whole respiratory 
pump is compromised in DMD, with a global 
weakness of all respiratory muscles with earlier 
impairment of the expiratory muscles followed 
by the inspiratory ones. As a consequence, severe 
restrictive lung pattern, inefficient cough, severe 
oxygen desaturation, uncontrolled hypercapnia, 
nocturnal hypoventilation, SDB and ultimately 
respiratory failure are expected in older DMD 
patients [2, 15, 30, 32–43].
Fascioscapulohumeral dystrophy
Fascioscapulohumeral dystrophy (FSH) is an 
autosomal dominant dystrophy with a prevalence of 
one in 20 000. Its name is derived from the groups 
of muscles primarily affected: facial and shoulder 
girdle; respiratory muscles tend to be spared. In 
20% of FSH patients, trunk muscles, particularly 
abdominal muscles that lead to a lordotic posture, 
may be involved as well and this may affect the 
ventilatory pump function. Facial muscle weakness 
may complicate spirometric assessment, which can 
yield less accurate results. Vital capacity and its two 
components, inspiratory capacity and expiratory 
reserve volume, are lower in FSH patients also when 
assessed by optoelectronic plethysmography, i.e. 
without the use of a mouthpiece. Maximal mouth 
pressures measurements may result unreliable. The 
weakness of upper airway muscles makes these 
patients prone to obstructive sleep apnoeas [1, 2, 
26, 30, 44, 45].
Limb-girdle muscular dystrophy
Limb-girdle muscular dystrophy (LGMD) is a 
heterogeneous group of autosomal dominant (types 
1A–1G) or recessive myopathies (types 2A–2L). 
The symptoms usually start to be evident around 
the second or third decades of life. Respiratory 
involvement is rare in LGMD1 but a restrictive 
pulmonary pattern may develop in case of severe 
scoliosis and spinal contracture-induced rigidity. 
The majority of LGMD2 patients have global 
respiratory muscle (both inspiratory and expiratory) 
involvement with significantly reduced contribution 
of the abdomen, particularly in wheelchair-bound 
patients. In type 2A, the involvement of the 
respiratory muscles occurs late. Type 2B LGMD 
shows a tendency for respiratory function to decline 
with disease duration. Types 2C–2F LGMD, or 
sarcoglycanopathy, show high respiratory morbidity 
with FVC below 40% of predicted values. LGMD 
2L patients develop diaphragmatic weakness, even 
in ambulant patients, with consequent chronic 




Emery–Dreifuss muscular dystrophy (EDMD) is a 
genetically heterogeneous dystrophy characterised 
by a triad of clinical features, namely, early 
contractures, progressive wasting and weakness 
of humeroperoneal muscles, and cardiomyopathy 
being the main cause of morbidity. EDMD patients 
also develop scoliosis and spinal rigidity that may 
lead up to a restrictive pulmonary pattern [1, 30].
Educational questions
1. Regarding muscular dystrophy, which of the following is true?
a)  In these patients, total lung capacity and vital capacity reduce, whereas 
functional residual capacity may be normal or lower.
b) Upper airway musculature is never involved in these patients.
c)  Chest wall becomes more elastic with the progression of the disease and 
therefore its compliance increases.
d)  Sleep disordered breathing occurs only in patients with high body mass 
index and craniofacial abnormalities.
2. A muscular dystrophic patient shows paradoxical thoracoabdominal 
movements during resting quiet breathing, characterised by outward 
ribcage movement and inward abdominal movement. The patient is:
a)  using the diaphragm to inspire and intercostal muscles to expire.
b) using the diaphragm to inspire with passive expiration.
c) using the intercostal muscles to inspire with passive expiration.
d) using the intercostal muscles to expire with passive inspiration.
3. How does the work of breathing (WOB) change in muscular dystrophy?
a)  It does not change because respiratory muscles are not affected by 
dystrophy.
b)  It does not change because although the resistive component of WOB 
increases, the elastic component of WOB decreases because the chest 
wall becomes more compliant over time.
c)  It increases because airway obstruction increases, and both chest wall 
and lung compliance decrease over time.
d)  It increases because airway obstruction decreases, the chest wall 
stiffens and the lungs become more elastic over time.
4. Is coughing altered in dystrophic patients?
a) No, because the muscles responsible for coughing are spared.
b)  Yes. It becomes more efficient thanks to a combination of physiotherapy 
and use of cough assisted devices.
c)  No, because although the inspiratory cough phase is compromised, the 
compressive and expiratory cough phases compensate for it.
d)  Yes. It becomes less efficient because of inspiratory, bulbar and 
expiratory muscles weakness that impairs the three cough phases
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Myotonic dystrophy type 1
With an incidence of one in 8000, myotonic 
dystrophy type 1 (MD1), or Steinert’s disease, 
is the most common muscular dystrophy in the 
adult population, with inheritance that occurs in 
an autosomal dominant manner. With a smaller 
incidence, congenital and childhood MD1 may also 
occur. In neonates, the mortality is around 25% by 
18 months of age, with respiratory failure being 
the main cause, while severe mental impairment 
remains in those who survive.
MD1 is a multisystem disorder with a 
typical clinical presentation of bilateral facial 
weakness, ptosis, muscle wasting, myotonia 
(i.e. after contraction, the muscle is delayed in 
its relaxation), cardiac conduction defects and 
intellectual impairment. Respiratory problems 
are typical and, with heart involvement, represent 
the most important cause of morbidity and 
mortality. Respiratory impairment usually starts 
in middle age, and it can present different and 
multiple manifestations: a progressive pulmonary 
restrictive pattern, irregularity in the breathing 
pattern (in terms of respiratory rate, tidal volume 
and fluctuation of resting expiratory levels) whilst 
awake, diaphragmatic paralysis, respiratory (both 
expiratory and inspiratory) muscles weakness, 
SDB, and obstructive or central apnoeas. These 
patients are also characterised by both abnormal 
afferent information from muscle spindles and 
impaired central respiratory pathways. The former 
seems to be the cause of the highly irregular 
breathing pattern while awake and the latter 
of hypercapnia and SDB. The high tendency 
toward hypercapnia and the early onset of SDB 
in MD1 is disproportionate, and greater than in 
nonmyotonic neuromuscular disease for similar 
levels of respiratory muscles weakness. These 
patients tend to be overweight, this being an 
additional factor that strongly affects the severity 
of nocturnal desaturation. Bulbar weakness can 
also be present, making MD1 patients prone to 
respiratory infection, while aspiration of gastric 
content may occur due to insufficient peristalsis. 
The cognitive impairment and the altered 
personality of these patients may hamper the 
efficacy of noninvasive mechanical ventilation 
[2, 15, 30, 46, 49–53].
Oculopharyngeal muscular 
dystrophy
This inherited disorder has an incidence of one in 
100 000, and can be either dominant or recessive. 
The onset of oculopharyngeal muscular dystrophy 
(OPMD) is around the third decade of life, and it 
affects extraocular, upper facial, neck, and proximal 
upper and even lower limb muscles. Typical clinical 
symptoms are ptosis, ophthalmoplegia and 
dysphagia. Although respiratory muscles are not 
involved and early respiratory involvement is very 
rare, bulbar weakness puts OPMD patients at risk of 
aspiration pneumonia and obstructive sleep apnoea 
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